January 22, 2025 By Mohammed Elkasaby, MD

Join Dr. Mohamed Elkasaby of University Hospitals Neurological Institute's Parkinson's Disease and Motion Disorders Center as he goes over both Lecanemab and Donanemab infusion therapy, and how they have actually shown promise in clinical trials, and may be a treatment alternative for clients with moderate cognitive problems and mild dementia due to Alzheimer's disease. More Info Source